Skip to main content
. 2021 Mar 28;26(8):651–659. doi: 10.1002/onco.13738

Table 3.

Impact of ctDNA‐positive status on recurrence risk [30]

3‐year RFI Kaplan‐Meier (%) Hazard ratio p value
Post‐surgery
ctDNA+ 47 3.8 <.001
ctDNA− 76
Post‐chemotherapy
ctDNA+ 30 6.8 <.001
ctDNA− 77

Abbreviations: ctDNA, circulating tumor DNA; RFI, relapse free interval.